T

Tessera Therapeutics

Gene Writing platform enabling precise edits

Quality Control Manager

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
ContractSomerville, MA, USA$60 - $70 /hrIn-person

About the Job

Requirements

  • A Bachelor of Science or Bachelor of Arts degree with at least 4 years of related experience, a Master of Science degree with at least 2 years of related experience, or a PhD with at least 3 years of related experience.
  • Quality Control experience supporting GMP testing and/or manufacturing of gene therapy or gene editing products, advanced therapy medicinal products, or equivalent.
  • Experience supporting or leading laboratory operations such as logistics for GMP manufacturing or testing, sample inventory management, and/or critical reagent program management.
  • Ability to multitask effectively while working independently and cross-functionally.

Responsibilities

  • Manage operational aspects of the QC laboratory, including laboratory maintenance activities and scheduling and coordination of GMP release and in-process testing.
  • Oversee sample management and logistics, including QC sample inventory management, sample transfer and receipt, and sample shipment to external test and storage sites.
  • Manage critical reagent programs and trend method performance.
  • Review QC data generated from compendial and platform assays to support GMP release and stability testing.
  • Lead aspects of QC laboratory operations and GMP method performance for analytical chemistry and molecular-based assays, managing GMP laboratory operations that support internal testing of drug substances and drug products.

About the Company

Tessera Therapeutics

Gene Writing platform enabling precise edits

Tessera Therapeutics focuses on genetic medicine by developing Gene Writing, a platform that makes precise and permanent changes to the human genome in cells. Its technology can perform both small and large genetic alterations, enabling targeted edits at the source of genetic diseases. The product works through a gene writing system that researchers and clinicians can apply to modify DNA sequences, with the aim of correcting disease-causing mutations. What sets Tessera apart is its emphasis on permanent, in vivo genome edits and a platform-driven approach supported by partnerships and licensing, rather than selling a single product. Revenue comes from collaborations with research institutions and pharmaceutical companies, licensing the Gene Writing technology, and potentially transferring proprietary tools to other biotech and healthcare organizations. The overarching goal is to cure genetic diseases by rewriting the genetic code, bringing about lasting therapeutic changes.

Company size
51-200
Company stage
Late Stage VC
Total funding
$682.7M
Headquarters
Somerville, MA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Tessera Therapeutics

See more jobs